Major Adverse Cardiac Events (MACE)

    Researchedby:
    Katie Jantz
    Last Updated: November 15, 2023

    Major adverse cardiac events (MACE), also known as major adverse cardiovascular events, is an umbrella term that represents a variety of severe cardiovascular outcomes. There is no standardized definition of MACE and it varies between studies, but it can include nonfatal heart attack, nonfatal stroke, cardiovascular mortality, all-cause mortality, unstable angina, heart failure, and unplanned coronary revascularization. MACE is used as a composite endpoint in research to help evaluate the effectiveness of an intervention in preventing serious cardiovascular events.

    Major Adverse Cardiac Events (MACE) falls under the Cardiovascular Health category.

    26,667 participants in 2 trials

    Examine Database: Major Adverse Cardiac Events (MACE)

    Research FeedRead all studies

    Update History

    Page created

    minor

    Research written by

    Examine Database References

    1. Alpha-Linolenic Acid (ALA) - Asmaa S Abdelhamid, Tracey J Brown, Julii S Brainard, Priti Biswas, Gabrielle C Thorpe, Helen J Moore, Katherine Ho Deane, Carolyn D Summerbell, Helen V Worthington, Fujian Song, Lee HooperOmega-3 fatty acids for the primary and secondary prevention of cardiovascular diseaseCochrane Database Syst Rev.(2020 Feb 29)
    2. Folic Acid (Vitamin B9) - Wang WW, Wang XS, Zhang ZR, He JC, Xie CLA Meta-Analysis of Folic Acid in Combination with Anti-Hypertension Drugs in Patients with Hypertension and Hyperhomocysteinemia.Front Pharmacol.(2017)